Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct:15:1571-1582.
doi: 10.2217/fmb-2020-0118. Epub 2020 Nov 20.

The role of pharmaceutical nanotechnology in the time of COVID-19 pandemic

Lígia N de M Ribeiro  1   2 , Belchiolina B Fonseca  1
Affiliations
Review

The role of pharmaceutical nanotechnology in the time of COVID-19 pandemic

Lígia N de M Ribeiro et al. Future Microbiol. 2020 Oct.

Abstract

There is no effective therapy against COVID-19 available so far. In the last months, different drugs have been tested as potential treatments for COVID-19, exhibiting high toxicity and low efficacy. Therefore, nanotechnology can be applied to improve the therapeutic action and minimize the toxicity of loaded drugs. In this review, we summarized the drugs tested as COVID-19 treatment and the advantages of antiviral nanostructured drug-delivery systems. Such systems have demonstrated low in vitro toxicity with better in vitro antiviral activity than free drugs. We believe that this approach should inspire novel nanostructured drug-delivery systems developments to find efficient COVID-19 treatments. Here, we discuss the remaining challenges for such promising nanosystems to be approved for clinical use.

Keywords: COVID-19; drug toxicity; nanostructured delivery systems; nanotechnology.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Illustrative chart of reported soft nanostructured drug delivery systems with antiviral properties, in terms of composition, nanoparticle size range (nm), ability to load molecules and its schematic representation.
See this image and copyright information in PMC

References

    1. Paules CI, Marston HD, Fauci AS. Coronavirus infections: more than just the common cold. JAMA 323(8), 707 (2020). - PubMed
    1. Hui DS, Azhar IE, Madani TA. et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health – The latest 2019 novel coronavirus outbreak in Wuhan, China. Int. J. Infect. Dis. 91, 264–266 (2020). - PMC - PubMed
    1. Sivasankarapillai VS, Pillai AM, Rahdar A. et al. On facing the SARS-CoV-2 (COVID-19) with combination of nanomaterials and medicine: possible strategies and first challenges. 10(5), E852 (2020). - PMC - PubMed
    1. Cojocaru FD, Botezat D, Gardikiotis I. et al. Nanomaterials designed for antiviral drug delivery transport across biological barriers. Pharmaceutics 12(2), 1–34 (2020). - PMC - PubMed

    2. •• The review highlighted the structure of nanocarriers loading the most of classes of antiviral molecules, focusing on their permeation ability at cellular and intracellular levels.

    1. Pereira BB. Challenges and cares to promote rational use of chloroquine and hydroxychloroquine in the management of coronavirus disease 2019 (COVID-19) pandemic: a timely review. J. Toxicol. Environ. Heal. – Part B Crit. Rev. 23(4), 177–181 (2020). - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources